CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug design.

[1]  Ziwei Huang,et al.  Identification of the CD8 DE Loop as a Surface Functional Epitope , 1998, The Journal of Biological Chemistry.

[2]  D. Zaller,et al.  X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. , 1997, Immunity.

[3]  Y. Chien,et al.  CD4 augments the response of a T cell to agonist but not to antagonist ligands. , 1997, Immunity.

[4]  D. Stuart,et al.  Crystal structure of the complex between human CD8αα and HLA-A2 , 1997, Nature.

[5]  W. Hendrickson,et al.  Dimeric association and segmental variability in the structure of human CD4 , 1997, Nature.

[6]  Ute Koch,et al.  Bioactive Peptide Design Based on Protein Surface Epitopes , 1997, The Journal of Biological Chemistry.

[7]  R. Germain,et al.  The Efficiency of CD4 Recruitment to Ligand-engaged TCR Controls the Agonist/Partial Agonist Properties of Peptide–MHC Molecule Ligands , 1997, The Journal of experimental medicine.

[8]  W. Hendrickson,et al.  Analysis of the contact sites on the CD4 molecule with class II MHC molecule: co-ligand versus co-receptor function. , 1997, Journal of immunology.

[9]  Partho Ghosh,et al.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.

[10]  Robyn L. Stanfield,et al.  An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex , 1996, Science.

[11]  R. Korngold,et al.  Identification of a Human CD4-CDR3-like Surface Involved in CD4+ T Cell Function* , 1996, The Journal of Biological Chemistry.

[12]  T. Satoh,et al.  Synthetic peptides derived from the fourth domain of CD4 antagonize off function and inhibit T cell activation. , 1996, Biochemical and biophysical research communications.

[13]  H. Grey,et al.  Antigen analogs as tools to study T-cell activation function and activation. , 1996, Seminars in immunology.

[14]  R. Germain,et al.  Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. , 1996, Seminars in immunology.

[15]  C. Auffray,et al.  Synthetic CD4 exocyclic peptides antagonize CD4 holoreceptor binding and T cell activation , 1996, Nature Biotechnology.

[16]  B. Braden,et al.  Crystal Structure of the Vα Domain of a T Cell Antigen Receptor , 1995, Science.

[17]  A. Smolyar,et al.  Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules. , 1995, Immunology today.

[18]  R. Germain,et al.  Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation , 1995, The Journal of experimental medicine.

[19]  Eric O Long,et al.  HLA-DR polymorphism affects the interaction with CD4 , 1995, The Journal of experimental medicine.

[20]  R. Mariuzza,et al.  Crystal structure of the beta chain of a T cell antigen receptor. , 1995, Science.

[21]  C. Janeway,et al.  Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. , 1994, Immunity.

[22]  R. Korngold,et al.  A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis , 1994, Nature.

[23]  P. Allen,et al.  Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. , 1993, Immunology today.

[24]  R. Meloen,et al.  Location of CD4 dimerization site explains critical role of CDR3-like region in HIV-1 infection and T-cell activation and implies a model for complex of coreceptor-MHC. , 1993, The Journal of biological chemistry.

[25]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[26]  K. Karjalainen,et al.  Mouse CD4 binds MHC class II with extremely low affinity. , 1993, International immunology.

[27]  D. Koshland,et al.  Prediction of the structure of a receptor–protein complex using a binary docking method , 1992, Nature.

[28]  J. Guardiola,et al.  Identification of a CD4 binding site on the β2 domain of HLA-DR molecules , 1992, Nature.

[29]  R. Germain,et al.  MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8 , 1992, Nature.

[30]  Richard Axel,et al.  Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution , 1992, Cell.

[31]  W. Hendrickson,et al.  Mutational analysis of the interaction between CD4 and class II MHC: Class II antigens contact CD4 on a surface opposite the gp120-binding site , 1991, Cell.

[32]  J M Thornton,et al.  Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. , 1991, Journal of molecular biology.

[33]  Thomas P. J. Garrett,et al.  Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains , 1990, Nature.

[34]  Peter D. Kwong,et al.  Crystal structure of an HIV-binding recombinant fragment of human CD4 , 1990, Nature.

[35]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[36]  D. Lamarre,et al.  The MHC-binding and gp120-binding functions of CD4 are separable. , 1989, Science.

[37]  C. Janeway,et al.  The Co‐Receptor Function of Murine CD4 1 , 1989 .

[38]  Michael A. Bookman,et al.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56 lck , 1988, Cell.

[39]  C. Janeway,et al.  The biologic activity of anti-T cell receptor V region monoclonal antibodies is determined by the epitope recognized. , 1988, Journal of immunology.

[40]  J. Strominger,et al.  Interaction between CD4 and class II MHC molecules mediates cell adhesion , 1987, Nature.

[41]  R. Huber,et al.  The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-A resolution. , 1975, Biochemistry.

[42]  R. Korngold,et al.  Immunoglobulin superfamily proteins: structure, mechanisms, and drug discovery. , 1997, Biopolymers.

[43]  R. Germain,et al.  The structural basis of CD4-MHC class II interactions: coreceptor contributions to T cell receptor antigen recognition and oligomerization-dependent signal transduction. , 1996, Current topics in microbiology and immunology.

[44]  C. Janeway,et al.  Ligands for the T-cell receptor: hard times for avidity models. , 1995, Immunology today.

[45]  M. Bevan,et al.  T cell receptor antagonists and partial agonists. , 1995, Immunity.

[46]  D. Littman.  The structure of the CD4 and CD8 genes. , 1987, Annual review of immunology.